Chun et al.
JOCArticle
SCHEME 1. Reactions of Diaryliodonium Salts with
[18F]Fluoride Ion
SCHEME 2. Routes Used for the Syntheses of Diaryliodonium
Salts in This Study
18O(p,n)18F reaction on 18O-enriched water, using a moderate-
energy proton beam from a compact cyclotron.2 This is a
highly productive nuclear reaction, capable of generating
multi-Curie levels of fluorine-18.
A major challenge in PET radiotracer development is to
find efficient methods for rapidly incorporating cyclotron-
produced [18F]fluoride ion into organic molecules. This may
be achieved at aliphatic sites and in electron-deficient arenes
by nucleophilic substitution reactions.1 A greater challenge is
the incorporation of [18F]fluoride ion into electron-rich
arenes, for which classical aromatic nucleophilic substitution
is generally a disfavored process, giving low or negligible
yields. The reactions of diaryliodonium salts with [18F]fluo-
ride ion3 (Scheme 1) do not share this limitation and may be
applied to labeling both electron-rich and electron-deficient
arenes with fluorine-18. These reactions have therefore
gained considerable interest.4-6 Notwithstanding, these
reactions exhibit unusual features, and their detailed
mechanisms are not yet well understood. As part of our
ongoing investigations into the scope and nature of these
reactions for PET radiotracer development, we wished to
explore the influence of substituents, particularly ortho
substituents, on reaction rates, energetics and product selec-
tivity under varied but well-controlled conditions. Here, we
show first the utility of a microreactor apparatus for this
radiochemical purpose and second further insights into the
mechanism and outcomes of the radiofluorination reaction.
These findings will assist in future PET radiotracer design
and production.
(Scheme 2). The derivatives of Koser’s reagent were prepared
by treating the appropriate iodoarene diacetate with p-tosic
acid.9 The reactions of Koser’s reagent and derivatives with
(tri(alkyl)stannyl)arenes exhibited excellent regioselectivity
and gave moderate (38%) to high yields (90%). Reactions
with arylboronic acids were regioselective for acids bearing
an o-methyl substituent but not for arylboronic acids bearing
an o-methoxy substituent. Yields were low (20%) to moder-
ate (49%). Direct reactions with mesitylene were effective for
making (mesityl)aryliodonium salts, since with the methyl
substitution pattern, only one positional isomer is possible.
Diaryliodonium tosylates were readily converted into their
corresponding halides in moderate (27%) to high yields
(88%) by metathesis reactions. In each case, metathesis
was readily confirmed by the absence of signals for tosylate
in the 1H NMR spectrum.
2.2. Radiofluorination Reactions within a Microreactor.
The potential advantages of microreactor technology for
PET radiochemistry are increasingly recognized.10,11 In this
study, all radiofluorination reactions were performed in a
commercially available microreactor apparatus (Nanotek;
Advion). The use of this apparatus offers several advantages
over traditional methods of studying radiofluorination reac-
tions, which are usually performed singly with substantial
amounts of nonradioactive precursor (e.g., milligram quan-
tities of precursor for labeling).1,6 As we have recently
shown,11 by use of the microreactor apparatus, a series of
reactions can be performed rapidly with very low fixed
quantities of reagents, under precisely controlled conditions
of temperature, time, and reaction stoichiometry. The whole
microreactor is heated to a controlled temperature, which
can be well above the boiling point of most organic solvents
due to the elevated pressure of the system. Because of the
small internal volume of the microreactor (15.7 μL for 2-m
2. Results and Discussion
2.1. Chemistry. Two main methods were used to prepare
substituted diaryliodonium tosylates, namely, reaction
of Koser’s reagent ([hydroxy(tosyloxy)]iodobenzene; PhI-
(OH)OTs) or an ortho-substituted derivative (RC6H4I(OH)-
OTs) with an arylboronic acid7 or tri(alkyl)stannylarene8
(2) (a) Guillaume, M.; Luxen, A.; Nebeling, B.; Argentini, M.; Clark,
J. C.; Pike, V. W. Appl. Radiat. Isot. 1992, 42, 749–762. (b) Qaim, S. M.; Clark,
J. C.; Crouzel, C.; Guillaume, M.; Helmeke, H. J.; Nebeling, B.; Pike,
€
V. W.; Stocklin, G. In Radiopharmaceuticals for Positron Emission Tomo-
€
graphy; Stocklin, G., Pike, V. W., Eds.; Kluwer Academic Publishers: Dordrecht,
Netherlands, 1993; pp 1-43.
(3) Pike, V. W.; Aigbirhio, F. I. J. Chem. Soc., Chem. Commun. 1995, 21,
2215–2216.
(4) (a) Shah, A.; Pike, V. W.; Widdowson, D. A. J. Chem. Soc., Perkin
Trans. 1 1998, 2043–2046. (b) Gail, R.; Hocke, C.; Coenen, H. H. J. Label.
Compd. Radiopharm. 1997, 40, 50–52. (c) Zhang, M. R.; Kumata, K.; Suzuki,
K. Tetrahedron Lett. 2007, 48, 8632–8635. (d) Pike, V. W.; Aigbirhio, F. I.
J. Label. Compd. Radiopharm. 1995, 37, 120–122.
´ ´
(5) Martın-Santamarıa, S.; Carroll, M. A.; Carroll, C. M.; Carter, C. D.;
Pike, V. W.; Rzepa, H. S.; Widdowson, D. A. Chem. Commun. 2000, 649–
650.
(6) Ross, L.; Ermert, J.; Hocke, C.; Coenen, H. H. J. Am. Chem. Soc.
2007, 129, 8018–8025.
(7) Carroll, M. A.; Pike, V. W.; Widdowson, D. A. Tetrahedron Lett.
2000, 41, 5393–5396.
(8) Pike, V. W.; Butt, F.; Shah, A.; Widdowson, D. A. J. Chem. Soc.,
Perkin Trans 1 1999, 245–248.
(9) (a) Neiland, G.; Karele, B. J. Org. Chem. USSR (Engl. Transl.) 1970,
889; Zh. Org. Khim. 19706, 885. (b) Koser, G. F.; Wettach, R. H. J. Org.
Chem. 1977, 42, 1476–1478.
(10) (a) Lu, S. Y.; Watts, P.; Chin, F. T.; Hong, J.; Musachio, J. L.; Briard,
E.; Pike, V. W. Lab Chip 2004, 4, 523–525. (b) Lee, C. C.; Sui, G. D.; Elizarov,
A.; Shu, C. Y. J.; Shin, Y. S.; Dooley, A. N.; Huang, J.; Daridon, A.; Wyatt,
P.; Stout, D.; Kolb, H. C.; Witte, O. N.; Satyamurthy, N.; Heath, J. R.;
Phelps, M. E.; Quake, S. R.; Tseng, H. R. Science 2005, 310, 1793–1796. (c)
Gillies, J. M.; Prenant, C.; Chimon, G. N.; Smethurst, G. J.; Perrie, W.;
Hamblett, I.; Dekker, B.; Zweit, J. Appl. Radiat. Isot. 2006, 64, 325–332. (d)
Steel, C. J.; O’Brien, A. T.; Luthra, S. K.; Brady, F. J. Label. Compd.
Radiopharm. 2007, 50, 308–311. (e) Lu, S. Y.; Pike, V. W. In PET Chemistry-
The Driving Force in Molecular Imaging; Schubiger, P. A., Lehmann, L., Friebe,
M., Eds.; Springer-Verlag: Heidelberg, 2007; pp 271-287. (f) Audrain, H.
Angew. Chem., Int. Ed. 2007, 46, 1772–1775. (g) Elizarov, A. M. Lab on Chip
2009, 9, 1326–1333.
(11) Lu, S.; Giamis, A. M.; Pike, V. W. Curr. Radiopharmaceuticals 2009,
2, 49–55.
J. Org. Chem. Vol. 75, No. 10, 2010 3333